TriSalus Life Sciences
TLSI
26 hedge funds and large institutions have $9.03M invested in TriSalus Life Sciences in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
54% more capital invested
Capital invested by funds: $5.85M → $9.03M (+$3.18M)
37% more funds holding
Funds holding: 19 → 26 (+7)
0.89% more ownership
Funds ownership: 2.62% → 3.51% (+0.89%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DFO
Duquesne Family Office
New York
|
+$2.92M |
| 2 |
Goldman Sachs
New York
|
+$503K |
| 3 |
BlackRock
New York
|
+$378K |
| 4 |
Millennium Management
New York
|
+$163K |
| 5 |
JP Morgan Chase
New York
|
+$97.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HC Advisors
Sandy Springs,
Georgia
|
-$860K |
| 2 |
HF
HRT Financial
New York
|
-$405K |
| 3 |
TWP
Tyche Wealth Partners
Plano,
Texas
|
-$154K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$152K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$137K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Macquarie Group
Sydney, NSW 2000,
Australia
| $3 | +$2.69K | +291 | New |
|
|
HA
27
HC Advisors
Sandy Springs,
Georgia
| – | -$860K | -101,736 | Closed |
|
|
HF
28
HRT Financial
New York
| – | -$405K | -48,011 | Closed |
|
|
29
Creative Planning
Overland Park,
Kansas
| – | -$137K | -16,216 | Closed |
|
TLSI Hedge Fund Activity: Q1 2024 in Review
26 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2024, worth a combined $9.03M — up 54% from $5.85M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TLSI positions and 3 closed out — a net gain of 7 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Duquesne Family Office, opening a new position worth an estimated $2.92M. The largest seller was HC Advisors, exiting entirely with an estimated $860K sold.
- 26 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2024, up from 19 in Q4 2023.
- Funds reported $9.03M of TriSalus Life Sciences stock for Q1 2024, up 54% quarter-over-quarter.
- 10 funds opened new TriSalus Life Sciences positions in Q1 2024 and 3 closed out, a net change of +7 holders.
- The largest TriSalus Life Sciences buyer in Q1 2024 was Duquesne Family Office, an estimated $2.92M added.
- The largest TriSalus Life Sciences seller in Q1 2024 was HC Advisors, an estimated $860K sold.
Based on aggregated 13F filings for Q1 2024.